_id
6913160cccc777a4e85d807c
Ticker
MGRX
Name
Mangoceuticals, Inc. Common Stock
Exchange
NASDAQ
Address
15110 N. Dallas Parkway, Dallas, TX, United States, 75248
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.mangoceuticals.com
Description
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Last Close
0.74
Volume
677568
Current Price
0.78
Change
0.1134
Last Updated
2026-01-05T10:26:59.319Z
Image
data:image/webp;base64,UklGRvgAAABXRUJQVlA4IOwAAACwBgCdASpAACIAPtFYqE8oJKOiKrQLAQAaCWUAVmf3kvozU2uYstChy/Luapqe9y4myZb/8wDuZzp9zlGG8AD+/vSaY//M5RIWF3TuvM1/A6raC8V5PbdecgodudmDtCOn1hH4LeyXf+qInaFrKo6mVY6I6c9yfQctbF//VbDjhATifdVg9cOJjlxod6wVGBQILG8Uz++0jGUCCWud/fcl8Dk9S0QPtNMh/YFHWGpUe33hQhz85WQe1cglawwa6qbS1ozj8MyW9pZKjkq5wY03RMkVKGWrukseg0od/owNhbaaLL56yotq+gAAAA==
Ipo Date
2023-03-21T00:00:00.000Z
Market Cap
13132799
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7468
Sentiment Sources
4
Rating
-
Target Price
-
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-09-30
Revenue
84246
Cost Of Revenue
33347
Gross Profit
50899
Operating Expenses
7593825
Operating Income
-7542926
Interest Expense
75850
Pretax Income
-7618776
Net Income
-7618218
Eps
-0.6610583312182328
Dividends Per Share
588000
Shares Outstanding
15388797
Income Tax Expense
-
EBITDA
-7518098
Operating Margin
-8953.452982930941
Total Other Income Expense Net
-75850
Cash
481281
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
598223
Property Plant Equipment
13260
Total Assets
16531802
Payables
526964
Short Term Debt
212167
Long Term Debt
-
Total Liabilities
804275
Equity
15729266
Bs_currency_symbol
USD
Depreciation
301473
Change In Working Capital
-432294
Cash From Operations
-1241264
Capital Expenditures
4
Cash From Investing
-
Cash From Financing
1621571
Net Change In Cash
380262
Cf_currency_symbol
USD
PE
-
PB
0.571478319458772
ROE
-48.43339797292512
ROA
-46.082199629538266
FCF
-1241268
Fcf Percent
-14.733850865322983
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
84246
Quarters > 0 > income Statement > cost Of Revenue
33347
Quarters > 0 > income Statement > gross Profit
50899
Quarters > 0 > income Statement > operating Expenses
7593825
Quarters > 0 > income Statement > operating Income
-7542926
Quarters > 0 > income Statement > interest Expense
75850
Quarters > 0 > income Statement > pretax Income
-7618776
Quarters > 0 > income Statement > net Income
-7618218
Quarters > 0 > income Statement > eps
-0.6610583312182328
Quarters > 0 > income Statement > dividends Per Share
588000
Quarters > 0 > income Statement > shares Outstanding
11524275
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7518098
Quarters > 0 > income Statement > operating Margin
-8953.452982930941
Quarters > 0 > income Statement > total Other Income Expense Net
-75850
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
481281
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
598223
Quarters > 0 > balance Sheet > property Plant Equipment
13260
Quarters > 0 > balance Sheet > total Assets
16531802
Quarters > 0 > balance Sheet > payables
526964
Quarters > 0 > balance Sheet > short Term Debt
212167
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
804275
Quarters > 0 > balance Sheet > equity
15729266
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7618218
Quarters > 0 > cash Flow > depreciation
301473
Quarters > 0 > cash Flow > change In Working Capital
-432294
Quarters > 0 > cash Flow > cash From Operations
-1241264
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1621571
Quarters > 0 > cash Flow > net Change In Cash
380262
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6610583312182328
Quarters > 0 > ratios > PB
0.571478319458772
Quarters > 0 > ratios > ROE
-48.43339797292512
Quarters > 0 > ratios > ROA
-46.082199629538266
Quarters > 0 > ratios > FCF
-1241268
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-14.733850865322983
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
168109
Quarters > 1 > income Statement > cost Of Revenue
78161
Quarters > 1 > income Statement > gross Profit
89948
Quarters > 1 > income Statement > operating Expenses
5358443
Quarters > 1 > income Statement > operating Income
-5268495
Quarters > 1 > income Statement > interest Expense
21700
Quarters > 1 > income Statement > pretax Income
-5415820
Quarters > 1 > income Statement > net Income
-5415818
Quarters > 1 > income Statement > eps
-0.5424836247778306
Quarters > 1 > income Statement > dividends Per Share
-588000
Quarters > 1 > income Statement > shares Outstanding
9983376
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4557886
Quarters > 1 > income Statement > operating Margin
-3133.9755753707414
Quarters > 1 > income Statement > total Other Income Expense Net
-147325
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
101019
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
117961
Quarters > 1 > balance Sheet > property Plant Equipment
29974
Quarters > 1 > balance Sheet > total Assets
20842828
Quarters > 1 > balance Sheet > payables
767996
Quarters > 1 > balance Sheet > short Term Debt
630117
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1600945
Quarters > 1 > balance Sheet > equity
19243064
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5415820
Quarters > 1 > cash Flow > depreciation
836234
Quarters > 1 > cash Flow > change In Working Capital
80963
Quarters > 1 > cash Flow > cash From Operations
-1256449
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1280785
Quarters > 1 > cash Flow > net Change In Cash
24523
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5424836247778306
Quarters > 1 > ratios > PB
0.4046670156062465
Quarters > 1 > ratios > ROE
-28.144260186423537
Quarters > 1 > ratios > ROA
-25.98408430948046
Quarters > 1 > ratios > FCF
-1256449
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-7.474013883849169
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
109306
Quarters > 2 > income Statement > cost Of Revenue
47242
Quarters > 2 > income Statement > gross Profit
62064
Quarters > 2 > income Statement > operating Expenses
4915253
Quarters > 2 > income Statement > operating Income
-4853189
Quarters > 2 > income Statement > interest Expense
13700
Quarters > 2 > income Statement > pretax Income
-4839489
Quarters > 2 > income Statement > net Income
-4839391
Quarters > 2 > income Statement > eps
-1.0536304422560718
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4593063
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4438197
Quarters > 2 > income Statement > operating Margin
-4440.002378643441
Quarters > 2 > income Statement > total Other Income Expense Net
13700
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
76496
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
0
Quarters > 2 > balance Sheet > total Current Assets
176652
Quarters > 2 > balance Sheet > property Plant Equipment
46330
Quarters > 2 > balance Sheet > total Assets
21753857
Quarters > 2 > balance Sheet > payables
1178180
Quarters > 2 > balance Sheet > short Term Debt
47713
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1503196
Quarters > 2 > balance Sheet > equity
20251840
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4839489
Quarters > 2 > cash Flow > depreciation
414992
Quarters > 2 > cash Flow > change In Working Capital
144518
Quarters > 2 > cash Flow > cash From Operations
-2274781
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
2285000
Quarters > 2 > cash Flow > net Change In Cash
17843
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.0536304422560718
Quarters > 2 > ratios > PB
0.17690190817229448
Quarters > 2 > ratios > ROE
-23.896055864553542
Quarters > 2 > ratios > ROA
-22.246128583082992
Quarters > 2 > ratios > FCF
-2274781
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-20.811126562128337
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
105247
Quarters > 3 > income Statement > cost Of Revenue
25144
Quarters > 3 > income Statement > gross Profit
80103
Quarters > 3 > income Statement > operating Expenses
1758000
Quarters > 3 > income Statement > operating Income
-1678000
Quarters > 3 > income Statement > interest Expense
-450598
Quarters > 3 > income Statement > pretax Income
-1949000
Quarters > 3 > income Statement > net Income
-1948000
Quarters > 3 > income Statement > eps
-0.6001896081544447
Quarters > 3 > income Statement > dividends Per Share
-802109
Quarters > 3 > income Statement > shares Outstanding
3245641
Quarters > 3 > income Statement > income Tax Expense
40
Quarters > 3 > income Statement > EBITDA
-1677000
Quarters > 3 > income Statement > operating Margin
-1594.344731916349
Quarters > 3 > income Statement > total Other Income Expense Net
-271000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
58653
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
75595
Quarters > 3 > balance Sheet > property Plant Equipment
62299
Quarters > 3 > balance Sheet > total Assets
15370511
Quarters > 3 > balance Sheet > payables
837501
Quarters > 3 > balance Sheet > short Term Debt
214962
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1425463
Quarters > 3 > balance Sheet > equity
13946129
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1948596
Quarters > 3 > cash Flow > depreciation
721788
Quarters > 3 > cash Flow > change In Working Capital
54126
Quarters > 3 > cash Flow > cash From Operations
-1129575
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1122498
Quarters > 3 > cash Flow > net Change In Cash
-15259
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.6001896081544447
Quarters > 3 > ratios > PB
0.18152707321149833
Quarters > 3 > ratios > ROE
-13.968033710286202
Quarters > 3 > ratios > ROA
-12.673618983780043
Quarters > 3 > ratios > FCF
-1129575
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-10.732609955628188
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
615873
Annuals > 0 > income Statement > cost Of Revenue
235909
Annuals > 0 > income Statement > gross Profit
379964
Annuals > 0 > income Statement > operating Expenses
8352000
Annuals > 0 > income Statement > operating Income
-7972000
Annuals > 0 > income Statement > interest Expense
13700
Annuals > 0 > income Statement > pretax Income
-8707000
Annuals > 0 > income Statement > net Income
-8706000
Annuals > 0 > income Statement > eps
-4.3992670920066335
Annuals > 0 > income Statement > dividends Per Share
-802109
Annuals > 0 > income Statement > shares Outstanding
1978966
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7962000
Annuals > 0 > income Statement > operating Margin
-1294.4227137737812
Annuals > 0 > income Statement > total Other Income Expense Net
-735000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
58653
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
75595
Annuals > 0 > balance Sheet > property Plant Equipment
62299
Annuals > 0 > balance Sheet > total Assets
15370511
Annuals > 0 > balance Sheet > payables
837501
Annuals > 0 > balance Sheet > short Term Debt
214962
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1425463
Annuals > 0 > balance Sheet > equity
13946129
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8707226
Annuals > 0 > cash Flow > depreciation
731469
Annuals > 0 > cash Flow > change In Working Capital
660377
Annuals > 0 > cash Flow > cash From Operations
-4863776
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
65000
Annuals > 0 > cash Flow > cash From Financing
4128268
Annuals > 0 > cash Flow > net Change In Cash
-680353
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.3992670920066335
Annuals > 0 > ratios > PB
0.12109808997177642
Annuals > 0 > ratios > ROE
-62.42592478529346
Annuals > 0 > ratios > ROA
-56.64092755276646
Annuals > 0 > ratios > FCF
-4863776
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-7.897368450963104
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
731493
Annuals > 1 > income Statement > cost Of Revenue
299992
Annuals > 1 > income Statement > gross Profit
431501
Annuals > 1 > income Statement > operating Expenses
9650391
Annuals > 1 > income Statement > operating Income
-9218890
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-9212417
Annuals > 1 > income Statement > net Income
-9212417
Annuals > 1 > income Statement > eps
-8.577669459962756
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1074000
Annuals > 1 > income Statement > income Tax Expense
1
Annuals > 1 > income Statement > EBITDA
-8093536
Annuals > 1 > income Statement > operating Margin
-1260.2841038806932
Annuals > 1 > income Statement > total Other Income Expense Net
6473
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
739006
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
18501
Annuals > 1 > balance Sheet > total Current Assets
818460
Annuals > 1 > balance Sheet > property Plant Equipment
215391
Annuals > 1 > balance Sheet > total Assets
1050793
Annuals > 1 > balance Sheet > payables
140765
Annuals > 1 > balance Sheet > short Term Debt
63718
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
276039
Annuals > 1 > balance Sheet > equity
774754
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-9212417
Annuals > 1 > cash Flow > depreciation
24889
Annuals > 1 > cash Flow > change In Working Capital
41512
Annuals > 1 > cash Flow > cash From Operations
-6997375
Annuals > 1 > cash Flow > capital Expenditures
3519
Annuals > 1 > cash Flow > cash From Investing
-3519
Annuals > 1 > cash Flow > cash From Financing
7057040
Annuals > 1 > cash Flow > net Change In Cash
56146
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.577669459962756
Annuals > 1 > ratios > PB
1.1830227401213804
Annuals > 1 > ratios > ROE
-1189.0764036068224
Annuals > 1 > ratios > ROA
-876.7109221321422
Annuals > 1 > ratios > FCF
-7000894
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-9.57069172227212
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
8939
Annuals > 2 > income Statement > cost Of Revenue
4089
Annuals > 2 > income Statement > gross Profit
4850
Annuals > 2 > income Statement > operating Expenses
1996432
Annuals > 2 > income Statement > operating Income
-1991582
Annuals > 2 > income Statement > interest Expense
6473
Annuals > 2 > income Statement > pretax Income
-1998055
Annuals > 2 > income Statement > net Income
-1998055
Annuals > 2 > income Statement > eps
-1.7309173349458085
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1154333
Annuals > 2 > income Statement > income Tax Expense
-224622
Annuals > 2 > income Statement > EBITDA
-1987719
Annuals > 2 > income Statement > operating Margin
-22279.695715404407
Annuals > 2 > income Statement > total Other Income Expense Net
-6473
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
682860
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
694605
Annuals > 2 > balance Sheet > property Plant Equipment
291740
Annuals > 2 > balance Sheet > total Assets
1003287
Annuals > 2 > balance Sheet > payables
33675
Annuals > 2 > balance Sheet > short Term Debt
224185
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
389257
Annuals > 2 > balance Sheet > equity
614030
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1998055
Annuals > 2 > cash Flow > depreciation
3863
Annuals > 2 > cash Flow > change In Working Capital
18869
Annuals > 2 > cash Flow > cash From Operations
-1346518
Annuals > 2 > cash Flow > capital Expenditures
43102
Annuals > 2 > cash Flow > cash From Investing
-43102
Annuals > 2 > cash Flow > cash From Financing
2049930
Annuals > 2 > cash Flow > net Change In Cash
660310
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.7309173349458085
Annuals > 2 > ratios > PB
1.6043316811882156
Annuals > 2 > ratios > ROE
-325.4002247447193
Annuals > 2 > ratios > ROA
-199.15089102121325
Annuals > 2 > ratios > FCF
-1389620
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-155.45586754670543
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
17520
Annuals > 3 > income Statement > operating Income
-17520
Annuals > 3 > income Statement > interest Expense
181
Annuals > 3 > income Statement > pretax Income
-17701
Annuals > 3 > income Statement > net Income
-17701
Annuals > 3 > income Statement > eps
-0.017742410786776335
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
997666
Annuals > 3 > income Statement > income Tax Expense
-70080
Annuals > 3 > income Statement > EBITDA
-17520
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-181
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
22550
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
22550
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
22550
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
39270
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
39270
Annuals > 3 > balance Sheet > equity
-16720
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-17701
Annuals > 3 > cash Flow > depreciation
3863
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-17520
Annuals > 3 > cash Flow > capital Expenditures
43102
Annuals > 3 > cash Flow > cash From Investing
-43102
Annuals > 3 > cash Flow > cash From Financing
40070
Annuals > 3 > cash Flow > net Change In Cash
22550
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.017742410786776335
Annuals > 3 > ratios > PB
-50.92154093301435
Annuals > 3 > ratios > ROE
105.86722488038278
Annuals > 3 > ratios > ROA
-78.49667405764966
Annuals > 3 > ratios > FCF
-60622
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
38
Valuation > metrics > PE
-0.6610583312182328
Valuation > metrics > PB
0.571478319458772
Valuation > final Score
70
Valuation > verdict
42.9% Undervalued
Profitability > metrics > ROE
-48.43339797292512
Profitability > metrics > ROA
-1273.4746072952728
Profitability > metrics > Net Margin
-90.42824585143508
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05113239231887871
Risk > metrics > Interest Coverage
-99.44529993408042
Risk > final Score
-338
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8093599104894802
Liquidity > metrics > Quick Ratio
0.8093599104894802
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-911
Prev Risks > 1
-1357
Prev Risks > 2
45
Prev Liquidities > 0
14
Prev Liquidities > 1
17
Prev Liquidities > 2
14
Updated At
2026-01-20T22:12:09.852Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.6611
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.57
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.05
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.08
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.9927
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.3742
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.5554
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.7984
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.6951
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-2.0497
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.23
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-06
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.06
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.06
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-09-26
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMangoceuticals (NASDAQ:MGRX) Stock Price Up 0.5% – Here’s Why Defense World
Read more →$MGRX stock is down 20% today. Here's what we see in our data. Quiver Quantitative
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Mangoceuticals, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.6611
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.